Medically Reviewed

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated September 21st, 2022

How Checkpoint Inhibitors Work in Lung Cancer

NOW
PLAYING
How to Treat Earlier Stage Lung Cancer -- Immunotherapy Drug Opdivo Before Surgery Shows Major Impact
NOW
PLAYING
Immunotherapy Has Changed The Game For Lung Cancer
NOW
PLAYING
Immunotherapy for Advanced Lung Cancer
NOW
PLAYING
How Does Atezolizumab (Tecentriq) Treat Lung Cancer?
NOW
PLAYING
Advanced Small Cell Lung Cancers Can Benefit from the Promising Immunotherapy Drug Keytruda Now, Too
NOW
PLAYING
New Options For People With Lung Cancer-- The Government Expands Approval For Immunotherapy As A First Treatment

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... lung cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Later Stage Treatment: The Importance of Biomarker Testing

SEE MORE   

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.

Later Stage Treatment: The Importance of Biomarker Testing

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.